Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konoplev

Showing results (211-220 of 259) with videos related to

Pageof 26
Sort By:
Cancer Biology & Therapy|December 14, 2007
PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APLYoko Tabe, Marina Konopleva, Yutaka Kondo, et al.
American Journal of Hematology|February 27, 2021
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabineKiyomi Morita, Nitin Jain, Hagop Kantarjian, et al.
Haematologica|November 3, 2022
Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphomaLianqun Qiu, Jie Xu, Pei Lin, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 1, 2008
Experimental and theoretical studies of a coaxial free-electron maser based on two-dimensional distributed feedbackI V Konoplev, A W Cross, A D R Phelps, et al.
Cytometry. Part B, Clinical Cytometry|June 18, 2022
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometryHong Fang, Sa A Wang, Shimin Hu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F MutationJuliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
American Journal of Hematology|May 13, 2016
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemiaTalha Badar, Damian R Handisides, Juliana M Benito, et al.
Annals of Diagnostic Pathology|November 25, 2021
Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantationMahsa Khanlari, Xiaoqiong Wang, Sanam Loghavi, et al.
American Journal of Hematology|April 6, 2022
Prediction of survival with intensive chemotherapy in acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2020
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myelomaSuyang Hao, Xinyan Lu, Zimu Gong, et al.
Pageof 26

Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Cancer Biology & Therapy|December 14, 2007
PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APLYoko Tabe, Marina Konopleva, Yutaka Kondo, et al.
American Journal of Hematology|February 27, 2021
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabineKiyomi Morita, Nitin Jain, Hagop Kantarjian, et al.
Haematologica|November 3, 2022
Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphomaLianqun Qiu, Jie Xu, Pei Lin, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 1, 2008
Experimental and theoretical studies of a coaxial free-electron maser based on two-dimensional distributed feedbackI V Konoplev, A W Cross, A D R Phelps, et al.
Cytometry. Part B, Clinical Cytometry|June 18, 2022
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometryHong Fang, Sa A Wang, Shimin Hu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F MutationJuliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
American Journal of Hematology|May 13, 2016
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemiaTalha Badar, Damian R Handisides, Juliana M Benito, et al.
Annals of Diagnostic Pathology|November 25, 2021
Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantationMahsa Khanlari, Xiaoqiong Wang, Sanam Loghavi, et al.
American Journal of Hematology|April 6, 2022
Prediction of survival with intensive chemotherapy in acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2020
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myelomaSuyang Hao, Xinyan Lu, Zimu Gong, et al.
Pageof 26